BioMedicine-Taiwan最新文献

筛选
英文 中文
Unveiling the power of flavonoids: A dynamic exploration of their impact on cancer through matrix metalloproteinases regulation. 揭开类黄酮的神秘面纱:通过基质金属蛋白酶调控对癌症影响的动态探索。
IF 2.1
BioMedicine-Taiwan Pub Date : 2024-06-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1447
Peramaiyan Rajendran
{"title":"Unveiling the power of flavonoids: A dynamic exploration of their impact on cancer through matrix metalloproteinases regulation.","authors":"Peramaiyan Rajendran","doi":"10.37796/2211-8039.1447","DOIUrl":"https://doi.org/10.37796/2211-8039.1447","url":null,"abstract":"<p><p>Cancer stands as a significant contributor to global mortality rates, primarily driven by its progression and widespread dissemination. Despite notable strides in cancer therapy, the efficacy of current treatment strategies is compromised due to their inherent toxicity and the emergence of chemoresistance. Consequently, there is a critical need to evaluate alternative therapeutic approaches, with natural compounds emerging as promising candidates, showcasing demonstrated anticancer capabilities in various research models. This review manuscript presents a comprehensive examination of the regulatory mechanisms governing the expression of matrix metalloproteinases (MMPs) and delves into the potential therapeutic role of flavonoids as agents exhibiting specific anticancer activity against MMPs. The primary aim of this study is to elucidate the diverse functions associated with MMP production in cancer and to investigate the potential of flavonoids in modulating MMP expression to inhibit metastasis.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 2","pages":"12-28"},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11204124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141472420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In vitro and in silico evaluation of Andrographis paniculata ethanolic crude extracts on fatty acid synthase expression on breast cancer cells. 穿心莲乙醇粗提取物对乳腺癌细胞脂肪酸合成酶表达的体外和硅学评估
IF 2.1
BioMedicine-Taiwan Pub Date : 2024-06-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1444
Nur Amanina Johari, Nur Anisa Sapi'i, Alvin Lu Jiunn Hieng, Nurriza Ab Latif, Syazwani Itri Amran, Rosnani Hasham, Khairunadwa Jemon
{"title":"<i>In vitro</i> and <i>in silico</i> evaluation of <i>Andrographis paniculata</i> ethanolic crude extracts on fatty acid synthase expression on breast cancer cells.","authors":"Nur Amanina Johari, Nur Anisa Sapi'i, Alvin Lu Jiunn Hieng, Nurriza Ab Latif, Syazwani Itri Amran, Rosnani Hasham, Khairunadwa Jemon","doi":"10.37796/2211-8039.1444","DOIUrl":"https://doi.org/10.37796/2211-8039.1444","url":null,"abstract":"<p><strong>Background: </strong>Fatty acid synthase (FASN), a key rate-limiting enzyme in the fatty acid biosynthesis pathway has been identified to be overexpressed in breast cancer. This overexpression has been affiliated with poor prognosis and resistance to chemotherapeutics. Consequently, FASN has come into focus as an appealing potential target for breast cancer treatment. Available FASN inhibitors, however, are unstable and have been correlated with adverse side effects.</p><p><strong>Objective: </strong>This present study aims to investigate the potential of <i>Andrographis paniculata</i> ethanolic crude extract (AP) as a potent FASN inhibitor in breast cancer cells.</p><p><strong>Materials & methods: </strong>This study used MTT assay and flow cytometry analysis to measure cell viability and apoptosis following AP treatment (0-500 μg/mL). Furthermore, FASN protein expression was evaluated using immunocytochemistry whereas lipid droplet formation was quantified using Oil Red O staining. Literature-based identified AP phytochemicals were subjected to the prediction of molecular docking and ADMET properties.</p><p><strong>Results: </strong>This study demonstrated that AP significantly reduced cell viability while inducing apoptosis in breast cancer cells. In addition, for the first time, exposure to AP was demonstrated to drastically reduce intracellular FASN protein expression and lipid droplet accumulation in EMT6 and MCF-7 breast cancer cells. Docking simulation analysis demonstrated AP phytochemicals may have exerted an inhibitory effect by targeting the FASN Thioesterase (TE) domain similarly to the known FASN inhibitor, Orlistat. Moreover, all AP phytochemicals also possessed drug-likeness properties which are in accordance with Lipinski's rule of five.</p><p><strong>Conclusions: </strong>These results highlight the potential of <i>A. paniculata</i> ethanolic crude extract as a FASN inhibitor and hence might have the potential to be further developed as a potent chemotherapeutic drug for breast cancer treatment.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 2","pages":"60-73"},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11204123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141472503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glutaminase - A potential target for cancer treatment. 谷氨酰胺酶--癌症治疗的潜在靶点。
IF 2.1
BioMedicine-Taiwan Pub Date : 2024-06-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1445
Josephine Anthony, Sureka Varalakshmi, Ashok Kumar Sekar, Nalini Devarajan, Balamurugan Janakiraman, Rajendran Peramaiyan
{"title":"Glutaminase - A potential target for cancer treatment.","authors":"Josephine Anthony, Sureka Varalakshmi, Ashok Kumar Sekar, Nalini Devarajan, Balamurugan Janakiraman, Rajendran Peramaiyan","doi":"10.37796/2211-8039.1445","DOIUrl":"https://doi.org/10.37796/2211-8039.1445","url":null,"abstract":"<p><p>The overexpression of glutaminase is reported to influence cancer growth and metastasis through glutaminolysis. Upregulation of glutamine catabolism is recently recognized as a critical feature of cancer, and cancer cells are observed to reprogram glutamine metabolism to maintain its survival and proliferation. Special focus is given on the glutaminase isoform, GLS1 (kidney type glutaminase), as the other isoform GLS2 (Liver type glutaminase) acts as a tumour suppressor in some conditions. Glutaminolysis linked with autophagy, which is mediated via mTORC1, also serves as a promising target for cancer therapy. Glutamine also plays a vital role in maintaining redox homeostasis. Inhibition of glutaminase aggravates oxidative stress by reducing glutathione level, thus leading to apoptotic-mediated cell death in cancer cells Therefore, inhibiting the glutaminase activity using glutaminase inhibitors such as BPTES, DON, JHU-083, CB-839, compound 968, etc. may answer many intriguing questions behind the uncontrolled proliferation of cancer cells and serve as a prophylactic treatment for cancer. Earlier reports neither discuss nor provide perspectives on exact signaling gene or pathway. Hence, the present review highlights the plausible role of glutaminase in cancer and the current therapeutic approaches and clinical trials to target and inhibit glutaminase enzymes for better cancer treatment.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 2","pages":"29-37"},"PeriodicalIF":2.1,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11204126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141472417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A brief literature review of low-level laser therapy for treating amyotrophic lateral sclerosis and confirmation of its effectiveness. 低强度激光疗法治疗肌萎缩性脊髓侧索硬化症的文献综述及其有效性的确认。
IF 1.7
BioMedicine-Taiwan Pub Date : 2024-03-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1430
Sergey V Moskvin
{"title":"A brief literature review of low-level laser therapy for treating amyotrophic lateral sclerosis and confirmation of its effectiveness.","authors":"Sergey V Moskvin","doi":"10.37796/2211-8039.1430","DOIUrl":"10.37796/2211-8039.1430","url":null,"abstract":"<p><strong>Introduction: </strong>Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with a steadily progressive course due to the death of central and peripheral motor neurons responsible for voluntary movements. Low-level laser therapy (LLLT) is a treatment method unique in its universality and efficacy, particularly for neurodegenerative diseases.</p><p><strong>Methods: </strong>In this review, we discuss the effect and application of LLLT in the treatment of ALS. A literature search for English and Russian publications for the keywords \"Amyotrophic Lateral Sclerosis\", \"Low-Level Laser Therapy\" was performed using PubMed, Scopus, Google Scholar, Web of Science and Russian Science Citation Index (RSCI) databases.</p><p><strong>Results: </strong>The article provided a brief literature review, substantiated the potential use of low-level laser therapy for ALS. The particular techniques of LLLT were developed.</p><p><strong>Conclusion: </strong>Based on the results of several studies and many years of successful experience with low-level laser therapy in Russia we conclude that a LLLT technique, including intravenous laser blood illumination (ILBI), noninvasive laser blood illumination (NLBI), and local exposure, is a promising treatment method for ALS.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 1","pages":"1-9"},"PeriodicalIF":1.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VKORC1 polymorphisms and complete resistance to vitamin K antagonists: About two cases. VKORC1 多态性和对维生素 K 拮抗剂的完全耐药性:关于两个病例
IF 1.7
BioMedicine-Taiwan Pub Date : 2024-03-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1434
Ilham Benyamna, Houda El Fissi, Fadoua Bouzid, Abdelhamid El Mousadik, Najat Alif
{"title":"VKORC1 polymorphisms and complete resistance to vitamin K antagonists: About two cases.","authors":"Ilham Benyamna, Houda El Fissi, Fadoua Bouzid, Abdelhamid El Mousadik, Najat Alif","doi":"10.37796/2211-8039.1434","DOIUrl":"10.37796/2211-8039.1434","url":null,"abstract":"<p><p>Complete resistance to vitamin K antagonists is a rare but serious condition. It can complicate therapeutic management, especially when direct oral anticoagulants cannot be used. Some single mutations in the VKORC1 gene have been identified in patients partially or completely resistant to vitamin K antagonists. We report the cases of two women in their fifties who presented an unexplained peripheral venous thrombosis. The aetiological assessment did not show any abnormalities. Genetic testing showed that both patients had the VKORC1 5417 GG genotype. The VKORC1 3673 genotype was GG in case 1 and GA in case 2. The two patients showed complete resistance to vitamin K antagonists which required a change in treatment with favourable outcomes. Our goal is to offer optimal care guided by a literature review.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 1","pages":"60-63"},"PeriodicalIF":1.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact and prevalence of comorbidities and complications on the severity of COVID-19 in association with age, gender, obesity, and pre-existing smoking: A meta-analysis. 合并症和并发症对 COVID-19 严重程度的影响和发生率与年龄、性别、肥胖和原有吸烟情况的关系:荟萃分析。
IF 1.7
BioMedicine-Taiwan Pub Date : 2024-03-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1429
Soulandi Djorwé, Amale Bousfiha, Néhémie Nzoyikorera, Joseph Nyandwi, Bellamine Kawthar, Abderrahim Malki
{"title":"Impact and prevalence of comorbidities and complications on the severity of COVID-19 in association with age, gender, obesity, and pre-existing smoking: A meta-analysis.","authors":"Soulandi Djorwé, Amale Bousfiha, Néhémie Nzoyikorera, Joseph Nyandwi, Bellamine Kawthar, Abderrahim Malki","doi":"10.37796/2211-8039.1429","DOIUrl":"10.37796/2211-8039.1429","url":null,"abstract":"<p><strong>Background: </strong>COVID-19 patients usually present multiple comorbidities and complications associated with severe forms of SARS-CoV-2 infection. This study aimed to assess the risk factors and prevalence of comorbidities and complications contributing to the severity of COVID-19.</p><p><strong>Methods: </strong>This meta-analysis was performed according to PRISMA guidelines. We searched various databases, including PubMed, Google Scholar, and Scopus (between 2020 and 2023), for eligible studies for this meta-analysis.</p><p><strong>Results: </strong>Thirty-three studies were eligible, including 85,812 patients, of which 36 % (30,634/85,812) had severe disease, whereas 64 % (55,178/85,812) had non-severe disease. Severe cases were potentially correlated with the following factors: gender (male) (odd ratio (OR) = 1.52, 95 % CI: 1.34-1.73), advanced age (OR = 3.06, 95 % CI: 2.18-4.40) pre-existing smoking (OR = 1.33, 95 % CI: 1.01-1.75), obesity (OR = 2.11, 95 % CI: 1.47-3.04), diabetes (OR = 1.81, 95 % CI: 1.35-2.43), hypertension (OR = 2.22, 95 % CI: 1.72-2.87), coronary heart disease (OR = 2.17, 95 % CI: 1.42-3.31), CKD (OR = 2.27, 95 % CI: 1.26-4.06), COPD (OR = 1.95, 95 % CI: 1.22-3.09), malignancy (OR = 1.63, 95 % CI: 1.07-2.49) and cerebrovascular disease (OR = 2.76, 95 % CI: 1.63-4.62). All these comorbidities were significantly higher in the severe COVID-19 group compared with the non-severe COVID-19 group. In addition, the most severe complications were associated with shock (OR = 28.08, 95 % CI: 3.49-226.03), ARDS (OR = 13.09, 95 % CI: 5.87-29.18), AKI (OR = 16.91, 95 % CI: 1.87-152.45) and arrhythmia (OR = 7.47, 95 % CI: 2.96-18.83). However, these complications were the most likely to prevent recovery in patients with severe affections compared with non-severe affection groups.</p><p><strong>Conclusion: </strong>All the comorbidities and complications listed above are more likely to cause severe forms of COVID-19 in some patients and hinder recovery. They are therefore risk factors to be controlled to minimize the undesirable effects of the disease.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 1","pages":"20-38"},"PeriodicalIF":1.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962561/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computational analysis of dimer G6PD structure to elucidate pathogenicity of G6PD variants. 通过对二聚体 G6PD 结构的计算分析,阐明 G6PD 变体的致病性。
IF 1.7
BioMedicine-Taiwan Pub Date : 2024-03-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1431
Shamini Chandran, Naveen Eugene Louis, Syazwani Itri Amran, Nurriza Ab Latif, Muaawia Ahmed Hamza, Mona Alonazi
{"title":"Computational analysis of dimer G6PD structure to elucidate pathogenicity of G6PD variants.","authors":"Shamini Chandran, Naveen Eugene Louis, Syazwani Itri Amran, Nurriza Ab Latif, Muaawia Ahmed Hamza, Mona Alonazi","doi":"10.37796/2211-8039.1431","DOIUrl":"10.37796/2211-8039.1431","url":null,"abstract":"<p><p>An inherent genetic enzyme disorder in humans, known as glucose-6-phosphate dehydrogenase (G6PD) deficiency, arises due to specific mutations. While the prevailing approach for investigating G6PD variants involves biochemical analysis, the intricate structural details remain limited, impeding a comprehensive understanding of how different G6PD variants of varying classes impact their functionality. This study 22 examined the dynamic properties of G6PD wild types and six G6PD variants from 23 different classes using molecular dynamic simulation (MDS). The wild-type and variant 24 G6PD structures unveil high fluctuations within the amino acid range of 274-515, the structural NADP<sup>+</sup> binding site, pivotal for enzyme dimerization. Specifically, two variants, G6PD<sub>Zacatecas</sub> (R257L) and G6PD<sub>Durham</sub> (K238R), demonstrate compromised structural stability at the dimer interface, attributable to the disruption of a salt bridge involving Glu 206 and Lys 407, along with the disturbance of hydrogen bonds formed by Asp 421 at the βN-βN sheets. Consequently, this impairment cascades to affect the binding affinity of crucial interactions, such as Lys 171-Glucose-6-Phosphate (G6P) and Lys 171-catalytic NADP<sup>+</sup>, leading to diminished enzyme activity. This study underscores the utility of computational in silico techniques in predicting the structural alterations and flexibility of G6PD variants. This insight holds promise for guiding future endeavors in drug development targeted at mitigating the impacts of G6PD deficiency.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 1","pages":"47-59"},"PeriodicalIF":1.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethanol leaf extracts of Anogeissus leiocarpus in antioxidants and hepatotoxic effects of Escherichia coli O157:H7 infected Swiss Mice. 雷公藤乙醇叶提取物对大肠杆菌 O157:H7 感染的瑞士小鼠的抗氧化和肝脏毒性作用。
IF 1.7
BioMedicine-Taiwan Pub Date : 2024-03-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1432
Fred C Akharaiyi, Chioma B Ehis-Eriakha, Peter T Olagbemide, Stephen E Akemu
{"title":"Ethanol leaf extracts of <i>Anogeissus leiocarpus</i> in antioxidants and hepatotoxic effects of <i>Escherichia coli</i> O157:H7 infected Swiss Mice.","authors":"Fred C Akharaiyi, Chioma B Ehis-Eriakha, Peter T Olagbemide, Stephen E Akemu","doi":"10.37796/2211-8039.1432","DOIUrl":"10.37796/2211-8039.1432","url":null,"abstract":"<p><strong>Introduction: </strong>Diseases caused by bacteria can be managed with medicinal plants with rightful dosage that will not affect body physiology and organs.</p><p><strong>Aim: </strong>This research aimed to evaluate the antioxidants and the effects of <i>Anogeisus leiocarpus</i> on liver function.</p><p><strong>Materials and methods: </strong>Ethanol leaf extracts were processed for antioxidants and hepatotoxic effects using animal models. Group one (negative control) was given access to water and regular feed, group two (positive control) was dosed with 107 CFU/ml of <i>Escherichia coli</i> O157:H7, and groups 3-6 were dosed with 107 <i>E</i>. <i>coli</i> O157:H7 for 3 days and treated with extract concentrations of 12, 25, 50 and 100 mg/kg bw respectively for seven days.</p><p><strong>Results: </strong>Higher ascorbic acid values in Ferric reducing antioxidant property (FRAP) and Hydroxyl radical scavenging (HRS) were recorded in the positive control (0.05 ± 0.01, 41 ± 0.05) than in the extract-treated (0.02 ± 0.14, 30 ± 0.02). Increase in DPPH (47 ± 0.1268 ± 0.05 %), Free radical scavenging property (FRAP) (0.03 ± 0.02-0.08 ± 0.14 %), and HRS (38 ± 0.14-68 ± 0.12 %) was observed in the extract. The lipid peroxidation (LPO) of the quote was 78.51 ± 2.16, GSH was 36.18 ± 3.18, and catalase was 78.42 ± 4.713. In the extract-treated, decreased values were recorded for LPO ((108.36 ± 1.12-70.19 ± 1.68 μM/g), while increased values were observed in Glutathione (GSH) (25.11 ± 2.64-33.62 ± 1.35 μM/g), and catalase (54.18 ± 2.14-60.25 ± 1.4 μM/g). The values of negative control for Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), and Alkaline phosphate (ALP) were lesser than what was received in the extract treated.</p><p><strong>Conclusion: </strong>The plant's traditional medicine usage is effective at low dosage and could be a suitable candidate for drug development which will not affect the body's physiology and organs. The subjecting of <i>A</i>. <i>leiocarpus</i> ethanol leaf extract to antioxidants assays and its effect on liver function have further proved its value in folklore medicine.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 1","pages":"39-46"},"PeriodicalIF":1.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomedicines in Longevity and Aging the Quest to Resist Biological Decline. 长寿与衰老中的生物医药--抵御生物衰退的探索》(Biomedicines in Longevity and Aging the Quest to Resist Biological Decline)。
IF 1.7
BioMedicine-Taiwan Pub Date : 2024-03-01 eCollection Date: 2024-01-01 DOI: 10.37796/2211-8039.1433
Raymond D Palmer
{"title":"Biomedicines in Longevity and Aging the Quest to Resist Biological Decline.","authors":"Raymond D Palmer","doi":"10.37796/2211-8039.1433","DOIUrl":"10.37796/2211-8039.1433","url":null,"abstract":"<p><p>Aging is considered part of the natural process of life, however in recent years medical literature has started to show that specific facets of aging are beginning to be understood and those factors may even be considered preventable with various measures. Aging is also considered the number one cause of poor quality of life, disease, disability, and death, so the importance of understanding the aging process and how to control certain aspects of it cannot be underestimated when age related suffering is factored in. The causes of aging are now becoming well understood, and in recent years many therapies have already become available to the public to attenuate specific corridors of aging. The heterogeneity of the aging process and the biological drivers involved is examined here in parallel with various compounds and therapies to combat biological decline. The benefits for governments in keeping their populations healthy and vibrant are vast, and at the same time offer a great incentive to invest into newly emerging technologies that may prevent the onset of preventable disease. Whilst this paper only discusses nine pathways to the aging process, many more exist.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"14 1","pages":"10-19"},"PeriodicalIF":1.7,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemical composition, mineral profile, anti-bacterial, and wound healing properties of snail slime of Helix aspersa Müller. Helix aspersa Müller 蜗牛粘液的化学成分、矿物质特征、抗菌和伤口愈合特性。
IF 1.7
BioMedicine-Taiwan Pub Date : 2023-12-01 eCollection Date: 2023-01-01 DOI: 10.37796/2211-8039.1424
Marouane Aouji, Amine Rkhaila, Bouchra Bouhaddioui, Malak Zirari, Hala Harifi, Youness Taboz, Lalla Aicha Lrhorfi, Rachid Bengueddour
{"title":"Chemical composition, mineral profile, anti-bacterial, and wound healing properties of snail slime of <i>Helix aspersa</i> Müller.","authors":"Marouane Aouji, Amine Rkhaila, Bouchra Bouhaddioui, Malak Zirari, Hala Harifi, Youness Taboz, Lalla Aicha Lrhorfi, Rachid Bengueddour","doi":"10.37796/2211-8039.1424","DOIUrl":"10.37796/2211-8039.1424","url":null,"abstract":"<p><p>Mucus is a substance made by snails that serves a variety of purposes and is increasingly employed in the medical and cosmetic industries. It includes bioactive compounds with a range of biological characteristics that could be useful in the treatment of particular issues. This study assessed the wound-healing efficiency, antibacterial activity, chemical and mineral composition of <i>Helix aspersa</i> Müller slime. Inductively Coupled Argon Plasma Atomic Emission Spectrometry (ICP-OES) was used for mineral analysis, while Gas chromatography coupled to mass spectrometry (GC-MS) analysis was used for chemical characterization. The findings showed that the <i>H. aspersa</i> Müller slime had inhibitory activity on the test samples. Additionally, it revealed significant healing activity. These findings point to the chemical composition and various biological activities of the <i>H. aspersa</i> Müller slime, which may be related to the animal's particular functions and be useful for medical applications. Our findings suggest that the <i>H. aspersa</i> Müller slime has biological effects related to antimicrobial activities and wound healing, and they pave the way for a more thorough investigation of its potential therapeutic effects.</p>","PeriodicalId":51650,"journal":{"name":"BioMedicine-Taiwan","volume":"13 4","pages":"10-19"},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140295232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信